DR info

Clinical trials : 40 / Drugs : 47 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 141

Drugs and their primary sponsors and trial info

18F-FDG
   Peking Union Medical College Hospital
      2012   Early Phase 1   NCT01665196   China;
68Ga-FAPI
   Peking Union Medical College Hospital
      2019   Early Phase 1   NCT04125511   China;
Abatacept
   Massachusetts General Hospital
      2018   Phase 2   NCT03669861   United States;
Acetaminophen
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
Afucosylated IgG1 kappa monoclonal antibody
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
   Viela Bio, Inc.
      2021   Phase 3   EUCTR2020-000417-33-SE   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000417-33-NL   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000417-33-PL   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000417-33-HU   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000417-33-DE   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Biliary stent
   Peking Union Medical College Hospital
      2016   -   NCT02797665   China;
CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Corticosteroids
   Peking Union Medical College Hospital
      2016   -   NCT02797665   China;
Diphenhydramine
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
Drug free, IS monotherapy and GC combined with IS
   Peking Union Medical College Hospital
      2019   -   NCT04124861   -
Elotuzumab
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
Extra blood draw samples
   Assistance Publique Hopitaux De Marseille
      2012   -   NCT02899039   France;
Famotidine
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
Glucocorticoids
   Principia Biopharma, a Sanofi Company
      2020   Phase 2   NCT04520451   Canada;United States;
Inebilizumab
   Katayama Sota
      2021   Phase 3   JPRN-jRCT2071210001   Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
   Viela Bio
      2020   Phase 3   NCT04540497   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Leflunomide
   Chinese PLA General Hospital
      2016   Phase 4   NCT02703194   China;
Lenalidomide
   Mayo Clinic
      2016   Phase 1   NCT02705638   United States;
METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Mayo Interactive Breath Hold Monitor
   Mayo Clinic
      2006   -   NCT00588367   United States;
Methionine
   Saitama Medical University International Medical Center
      2016   -   JPRN-UMIN000019908   Japan;
Methylprednisolone
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU
   VIELABIO Inc.
      2020   Phase 3   EUCTR2020-000417-33-IT   Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Perflubutane
   Department of EndoscopyThe Jikei University School of Medicine
      2018   -   JPRN-UMIN000030735   Japan;
Prednisolone
   Department of Gastroenterology, University of Tokyo
      2010   -   JPRN-UMIN000003804   Japan;
   Osaka University
      2016   -   JPRN-UMIN000022633   Japan;
Prednisone
   Chinese PLA General Hospital
      2016   Phase 4   NCT02703194   China;
   Katayama Sota
      2021   Phase 3   JPRN-jRCT2071210001   Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
   National Institute of Allergy and Infectious Diseases (NIAID)
      2021   Phase 2   NCT04918147   United States;
   Peking Union Medical College Hospital
      2012   Phase 2/Phase 3   NCT01758393   China;
Prednisone and Belimumab
   Peking Union Medical College Hospital
      2021   Phase 4   NCT04660565   China;
Prednisone and Mycophenolate mofetil
   Peking Union Medical College Hospital
      2015   Phase 2   NCT02458196   China;
Rilzabrutinib
   Principia Biopharma, a Sanofi Company
      2020   Phase 2   NCT04520451   Canada;United States;
Rituximab
   Massachusetts General Hospital
      2012   Phase 1/Phase 2   NCT01584388   United States;
   Mayo Clinic
      2016   Phase 1   NCT02705638   United States;
T 614
   Wen Zhang
      2017   Phase 4   NCT03368274   China;
Thalidomide
   Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
      2020   Phase 4   ChiCTR2000028918   China;
Uplizna
   Viela Bio, Inc.
      2021   Phase 3   EUCTR2020-000417-33-SE   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2021   Phase 3   EUCTR2020-000417-33-NL   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000417-33-PL   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
      2020   Phase 3   EUCTR2020-000417-33-DE   Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
XmAb5871
   Xencor INC
      2019   Phase 3   EUCTR2017-002214-31-IT   Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;United States;
   Xencor, Inc.
      2016   Phase 2   NCT02725476   United States;
Zanubrutinib
   Matthew C. Baker
      2022   Phase 2   NCT04602598   United States;